Les publications scientifiques permettent de partager nos découvertes avec nos collègues du monde entier.

Avec plus de 150 publications depuis sa création, l’IRHT connaît un rayonnement international.

Publications Scientifiques, Cellules SouchesQuelques-unes de nos dernières publications :


  1. Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe
    Hénon P, Kowalczyk M, Aries A, Vignon C, Trébuchet G, Lahlil R
    Stem Cell Reviews and Reports 2022, https://doi.org/10.1007/s12015-022-10373-5. Cliquer pour accéder au site de l’éditeur ou l’article complet en pdf (Anglais)
  2. CD34+ Stem Cells and Regenerative Medicine                                                                                                                                                  Henon P, Lahlil R.                                                                                                                                                                                                     Stem Cells pp 21–34. First on line 01 December 2021. Cliquer pour télécharger  
  3. Purification of CD34+ Stem Cells from Myelodysplastic Syndrome with Ring Sideroblasts using Immunomagnetic Strategy.
    Barbet R, Eidenschenk A, Harzallah I, Hénon P, Drénou B. 
    Biomedical Journal of Scientific & Technical Research March, 2021, Volume 34, 5, pp 27062-27069. Lire le résumé (Français), Accéder au site de l’éditeur ou l’article complet en pdf
  4. Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells.
    Lahlil R, Scrofani M, Aries A, Hénon P, Drénou B. 
    Biology 2021, 10, 312. https://doi.org/10.3390/ biology10040312. Cliquer pour lire le résumé ou l’article complet en pdf (Anglais)
  5. Fibrous biomaterials : Effect of textile topography on foreign body reaction.
    Girault E, Biguenet F, Eidenschenk A, Dupuis D, Barbet R, Heim F.
    J Biomed Mater Res B Appl Biomater. 2021 Feb 1. doi : 10.1002/jbm.b.34810. Cliquer pour lire le résumé (Anglais) ou en Français sur notre page actualité
  6. CD34+ Very Small Embryonic-Like Stem Cells or Induced Pluripotent Stem Cells for Cardiac Repair.
    Henon P, Lahlil R and Aries A.
    Journal of Cardiology and Vascular Medicine. 2020 ; 6 : 1-12. Cliquer pour Télécharger
  7. Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34 + Cells for Clinical Use After Myocardial Infarction.                                                                                                                                                                                               Saucourt C, Vogt S, Merlin A, Valat C, Criquet A, Harmand L, Birebent B, Rouard H, Himmelspach C, Jeandidier E, Chartois-Leauté A-G, Derenne S, Koehl L, Salem J-E, Hulot J-S, Tancredi  C, Aries A, Judé S, Martel E, Richard S, Douay L, Hénon P.                                                             Stem Cells Transl Med. 2019 Aug;8(8):822-832. doi : 10.1002/sctm.17-0277. Epub 2019 Apr 29. Cliquer pour Télécharger
  8. VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion                                                   Lahlil R, Scrofani M, Barbet R, Tancredi C, Aries A, Hénon P.                                                                                                                                  Published : 08 May 2018 Cliquer pour Télécharger
  9. Human Very Small Embryonic-Like Stem Cells Are Present in Normal Peripheral Blood of Young, Middle-Aged, and Aged Subjects.
    Sovalat H, Scrofani M, Eidenschenk A, Hénon P.
    Stem Cells Int. 2016 ; 2016:7651645.
  10. Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
    Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C.
    Bioorg Med Chem. 2013 Apr 1 ; 21(7):2135-44.
  11. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H, Scrofani M, Eidenschenk A, Pasquet S, Rimelen V, Hénon P.
    Exp Hematol. 2011 Apr ; 39(4):495-505.
  12. Three-dimensional distribution patterns of CD34 antigen on nonactivated cord blood cells.
    Jung G, Wunder E, Dieterlen A, Hénon P, Jacquey S.
    Cytometry A. 2008 Jan ; 73(1):16-21.
  13. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
    Pasquet S, Sovalat H, Hénon P, Bischoff N, Arkam Y, Ojeda-Uribe M, Bouar Rl, Rimelen V, Brink I, Dallemand R, Monassier JP.
    Cytotherapy. 2009;11(8):1002-15.
  14. Relative quantification of residual tumor cells by lightcycler real-time IgH PCR in autografted multiple myeloma patients.
    Rimelen V, Ferrand C, Debecker A, Sovalat H, Tancredi C, Eidenschenk A, Hénon P.
    Leukemia. 2005 Mar ; 19(3):492-5.
  15. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
    Ojeda-Uribe M, Sovalat H, Bourderont D, Brunot A, Marr A, Lewandowski H, Chabouté V, Peter P, Henon P.
    Cytotherapy. 2004;6(6):571-83.
  16. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
    Sovalat H, Racadot E, Ojeda M, Lewandowski H, Chabouté V, Hénon P.
    J Hematother Stem Cell Res. 2003 Oct;12(5):473-89.
  17. Importance of CD34+ cell subsets in autologous PBSC transplantation : the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
    Hénon PH, Sovalat H, Bourderont D.
    J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):62-7. Review.
  18. Human accessory cells have a humoral bystander effect on CAFC growing on murine feeder.
    Mazini L, Wunder E, Sovalat H, Jung G, Bourderont D, Bachorz J, Bearenzung M, Zanetti C, Hénon P.
    J Hematother Stem Cell Res. 2000 Oct;9(5):749-57.